{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:47:54Z","timestamp":1790117274082,"version":"4.0.1"},"reference-count":206,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014895","name":"Southwest Medical University","doi-asserted-by":"publisher","award":["2020XSJG-C01-19"],"award-info":[{"award-number":["2020XSJG-C01-19"]}],"id":[{"id":"10.13039\/501100014895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014895","name":"Southwest Medical University","doi-asserted-by":"publisher","award":["JG2018043"],"award-info":[{"award-number":["JG2018043"]}],"id":[{"id":"10.13039\/501100014895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Provincial Science and Technology Support Program","doi-asserted-by":"publisher","award":["2022YFS0610"],"award-info":[{"award-number":["2022YFS0610"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014764","name":"China International Medical Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014764","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013254","name":"National College Students Innovation and Entrepreneurship Training Program","doi-asserted-by":"publisher","award":["202310632050"],"award-info":[{"award-number":["202310632050"]}],"id":[{"id":"10.13039\/501100013254","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.intimp.2024.113722","type":"journal-article","created":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T16:42:32Z","timestamp":1733071352000},"page":"113722","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Mitochondria dysfunction: A trigger for cardiovascular diseases in systemic lupus erythematosus"],"prefix":"10.1016","volume":"144","author":[{"given":"Haitao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinyu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.intimp.2024.113722_b0005","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/nrrheum.2016.186","article-title":"New insights into the immunopathogenesis of systemic lupus erythematosus","volume":"12","author":"Tsokos","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.intimp.2024.113722_b0010","article-title":"Mitochondrial impairment and repair in the pathogenesis of systemic lupus erythematosus","volume":"13","author":"Zhao","year":"2022","journal-title":"Front Immunol"},{"issue":"17","key":"10.1016\/j.intimp.2024.113722_b0015","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1016\/j.cell.2021.07.021","article-title":"Erythroid mitochondrial retention triggers myeloid-dependent type I interferon in human SLE","volume":"184","author":"Caielli","year":"2021","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.intimp.2024.113722_b0020","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/s41584-019-0332-5","article-title":"Targeting mitochondrial dysfunction in SLE","volume":"15","author":"McHugh","year":"2019","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"10.1016\/j.intimp.2024.113722_b0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/15548627.2019.1603547","article-title":"Emerging views of mitophagy in immunity and autoimmune diseases","volume":"16","author":"Xu","year":"2020","journal-title":"Autophagy"},{"key":"10.1016\/j.intimp.2024.113722_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110246","article-title":"Role of T cells in the pathogenesis of systemic lupus erythematous: Focus on immunometabolism dysfunctions","volume":"119","author":"Saadh","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.intimp.2024.113722_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mito.2016.05.007","article-title":"The pathogenesis of systemic lupus erythematosus - From the viewpoint of oxidative stress and mitochondrial dysfunction","volume":"30","author":"Lee","year":"2016","journal-title":"Mitochondrion"},{"key":"10.1016\/j.intimp.2024.113722_b0040","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.tox.2017.07.016","article-title":"Mitochondrial dysfunction as a trigger of innate immune responses and inflammation","volume":"391","author":"West","year":"2017","journal-title":"Toxicology"},{"issue":"2","key":"10.1016\/j.intimp.2024.113722_b0045","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.4049\/jimmunol.169.2.1092","article-title":"Persistent mitochondrial hyperpolarization, increased reactive oxygen intermediate production, and cytoplasmic alkalinization characterize altered IL-10 signaling in patients with systemic lupus erythematosus","volume":"169","author":"Gergely","year":"2002","journal-title":"J Immunol"},{"issue":"20","key":"10.1016\/j.intimp.2024.113722_b0050","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20205183","article-title":"Cross-Talk between Mitochondrial Dysfunction-Provoked Oxidative Stress and Aberrant Noncoding RNA Expression in the Pathogenesis and Pathophysiology of SLE","volume":"20","author":"Tsai","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.intimp.2024.113722_b0055","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejim.2023.02.004","article-title":"Mortality and causes of death in systemic lupus erythematosus over the last decade: Data from a large population-based study","volume":"112","author":"Zen","year":"2023","journal-title":"Eur J Intern Med"},{"issue":"1","key":"10.1016\/j.intimp.2024.113722_b0060","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/ard-2023-224762","article-title":"EULAR recommendations for the management of systemic lupus erythematosus: 2023 update","volume":"83","author":"Fanouriakis","year":"2024","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.intimp.2024.113722_b0065","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/joim.13557","article-title":"Systemic lupus erythematosus and cardiovascular disease","volume":"293","author":"Frosteg\u00e5rd","year":"2023","journal-title":"J Intern Med"},{"issue":"8","key":"10.1016\/j.intimp.2024.113722_b0070","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.mayocp.2019.01.044","article-title":"Systemic Lupus Erythematosus and Increased Prevalence of Atherosclerotic Cardiovascular Disease in Hospitalized Patients","volume":"94","author":"Katz","year":"2019","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"10.1016\/j.intimp.2024.113722_b0075","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1093\/rheumatology\/kez456","article-title":"Outcomes of acute cardiovascular events in rheumatoid arthritis and systemic lupus erythematosus: a population-based study","volume":"59","author":"Lai","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.intimp.2024.113722_b0080","first-page":"733","article-title":"Cardiovascular Risk Factors and Prevention: A Perspective From Developing Countries","volume":"37","author":"Teo","year":"2021","journal-title":"Can J Cardiol"},{"issue":"24","key":"10.1016\/j.intimp.2024.113722_b0085","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232416053","article-title":"Mitochondrial Dysfunction and Therapeutic Perspectives in Cardiovascular Diseases","volume":"23","author":"Liu","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.intimp.2024.113722_b0090","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1186\/s12967-023-04498-5","article-title":"Mitochondrial dysfunction at the crossroad of cardiovascular diseases and cancer","volume":"21","author":"Rocca","year":"2023","journal-title":"J Transl Med"},{"issue":"1","key":"10.1016\/j.intimp.2024.113722_b0095","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2017-000221","article-title":"Associates and predictors of pleurisy or pericarditis in SLE","volume":"4","author":"Ryu","year":"2017","journal-title":"Lupus Sci Med"},{"issue":"3","key":"10.1016\/j.intimp.2024.113722_b0100","doi-asserted-by":"crossref","first-page":"275","DOI":"10.4065\/74.3.275","article-title":"Cardiac involvement in systemic lupus erythematosus","volume":"74","author":"Moder","year":"1999","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.intimp.2024.113722_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100904","article-title":"Mitochondrial metabolism regulates macrophage biology","volume":"297","author":"Wang","year":"2021","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.intimp.2024.113722_b0110","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.pop.2023.07.006","article-title":"Myocarditis and Pericarditis","volume":"51","author":"Spotts","year":"2024","journal-title":"Prim Care"},{"issue":"13","key":"10.1016\/j.intimp.2024.113722_b0115","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1177\/0961203312456752","article-title":"A contemporary case series of lupus myocarditis","volume":"21","author":"Zawadowski","year":"2012","journal-title":"Lupus"},{"issue":"3","key":"10.1016\/j.intimp.2024.113722_b0120","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/rheumatology\/kem371","article-title":"Associated factors and impact of myocarditis in patients with SLE from LUMINA, a multiethnic US cohort","volume":"47","author":"Apte","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"10.1016\/j.intimp.2024.113722_b0125","doi-asserted-by":"crossref","first-page":"468","DOI":"10.4070\/kcj.2024.0033","article-title":"Proteome-wide Characterization and Pathophysiology Correlation in Non-ischemic Cardiomyopathies","volume":"54","author":"Lee","year":"2024","journal-title":"Korean Circ J"},{"issue":"36","key":"10.1016\/j.intimp.2024.113722_b0130","doi-asserted-by":"crossref","first-page":"11389","DOI":"10.1073\/pnas.1513047112","article-title":"Mitochondrial calcium overload is a key determinant in heart failure","volume":"112","author":"Santulli","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/j.intimp.2024.113722_b0135","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMra071667","article-title":"Myocardial reperfusion injury","volume":"357","author":"Yellon","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.intimp.2024.113722_b0140","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.freeradbiomed.2023.08.009","article-title":"The role of mitochondria in myocardial damage caused by energy metabolism disorders: From mechanisms to therapeutics","volume":"208","author":"Li","year":"2023","journal-title":"Free Radic Biol Med"},{"issue":"12","key":"10.1016\/j.intimp.2024.113722_b0145","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1113\/JP273609","article-title":"Mitochondrial energetics and calcium coupling in the heart","volume":"595","author":"Kohlhaas","year":"2017","journal-title":"J Physiol"},{"issue":"4","key":"10.1016\/j.intimp.2024.113722_b0150","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1161\/01.RES.0000258450.44413.96","article-title":"Mitochondrial dysfunction in atherosclerosis","volume":"100","author":"Madamanchi","year":"2007","journal-title":"Circ Res"},{"issue":"8","key":"10.1016\/j.intimp.2024.113722_b0155","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/j.hrthm.2016.05.002","article-title":"Mitochondrial oxidative stress during cardiac lipid overload causes intracellular calcium leak and arrhythmia","volume":"13","author":"Joseph","year":"2016","journal-title":"Heart Rhythm"},{"issue":"1","key":"10.1016\/j.intimp.2024.113722_b0160","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3892\/ijmm.2023.5329","article-title":"mROS\u2011calcium feedback loop promotes lethal ventricular arrhythmias and sudden cardiac death in early myocardial ischemia","volume":"53","author":"Zhou","year":"2024","journal-title":"Int J Mol Med"},{"issue":"2","key":"10.1016\/j.intimp.2024.113722_b0165","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00414-020-02481-z","article-title":"Sudden cardiac death-update","volume":"135","author":"Markwerth","year":"2021","journal-title":"Int J Legal Med"},{"issue":"1","key":"10.1016\/j.intimp.2024.113722_b0170","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41392-024-01839-8","article-title":"Mitochondrial dysfunction: mechanisms and advances in therapy","volume":"9","author":"Zong","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"10.1016\/j.intimp.2024.113722_b0175","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/09612033231164635","article-title":"Mitochondrial bioenergetic changes in systemic lupus erythematosus immune cell subsets: Contributions to pathogenesis and clinical applications","volume":"32","author":"Yennemadi","year":"2023","journal-title":"Lupus"},{"issue":"5","key":"10.1016\/j.intimp.2024.113722_b0180","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/BOR.0000000000000528","article-title":"Cardiovascular disease in systemic lupus erythematosus: an update","volume":"30","author":"Liu","year":"2018","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"10.1016\/j.intimp.2024.113722_b0185","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2020-000454","volume":"8","author":"Ajeganova","year":"2021","journal-title":"Lupus Sci Med"},{"issue":"1","key":"10.1016\/j.intimp.2024.113722_b0190","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2019-000346","article-title":"Development of a systemic lupus erythematosus cardiovascular risk equation","volume":"6","author":"Petri","year":"2019","journal-title":"Lupus Sci Med"},{"issue":"1","key":"10.1016\/j.intimp.2024.113722_b0195","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40659-018-0182-7","article-title":"Increased ROS production and DNA damage in monocytes are biomarkers of aging and atherosclerosis","volume":"51","author":"Jacinto","year":"2018","journal-title":"Biol Res"},{"issue":"2","key":"10.1016\/j.intimp.2024.113722_b0200","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41419-019-1400-0","article-title":"Altered mitochondrial quality control in Atg7-deficient VSMCs promotes enhanced apoptosis and is linked to unstable atherosclerotic plaque phenotype","volume":"10","author":"Nahapetyan","year":"2019","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.intimp.2024.113722_b0205","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1038\/s41598-019-40419-7","article-title":"Impaired mitochondrial oxidative phosphorylation capacity in epicardial adipose tissue is associated with decreased concentration of adiponectin and severity of coronary atherosclerosis","volume":"9","author":"Nakajima","year":"2019","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.intimp.2024.113722_b0210","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.atherosclerosis.2013.01.006","article-title":"Changes of mitochondria in atherosclerosis: possible determinant in the pathogenesis of the disease","volume":"227","author":"Sobenin","year":"2013","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.intimp.2024.113722_b0215","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3390\/cells10020443","article-title":"Autophagy and Mitophagy as Essential Components of Atherosclerosis","volume":"10","author":"Poznyak","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2024.113722_b0220","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1039241","article-title":"ROS-triggered endothelial cell death mechanisms: Focus on pyroptosis, parthanatos, and ferroptosis","volume":"13","author":"Zheng","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.intimp.2024.113722_b0225","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1186\/s12967-023-04270-9","article-title":"Inhibition of DRP1-dependent mitochondrial fission by Mdivi-1 alleviates atherosclerosis through the modulation of M1 polarization","volume":"21","author":"Su","year":"2023","journal-title":"J Transl Med"},{"issue":"11","key":"10.1016\/j.intimp.2024.113722_b0230","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1161\/CIRCRESAHA.117.311082","article-title":"Autophagy and Mitophagy in Cardiovascular Disease","volume":"120","author":"Bravo-San Pedro","year":"2017","journal-title":"Circ Res"},{"issue":"4","key":"10.1016\/j.intimp.2024.113722_b0235","doi-asserted-by":"crossref","DOI":"10.1172\/JCI159498","article-title":"Mitochondrial dysfunction in macrophages promotes inflammation and suppresses repair after myocardial infarction","volume":"133","author":"Cai","year":"2023","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1016\/j.intimp.2024.113722_b0240","doi-asserted-by":"crossref","DOI":"10.2196\/29928","article-title":"mHealth Interventions for Lifestyle and Risk Factor Modification in Coronary Heart Disease: Randomized Controlled Trial","volume":"9","author":"Bae","year":"2021","journal-title":"JMIR Mhealth Uhealth"},{"issue":"6","key":"10.1016\/j.intimp.2024.113722_b0245","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1002\/jcsm.13340","article-title":"Obesity, metabolic health and clinical outcomes after incident cardiovascular disease: A nationwide population-based cohort study","volume":"14","author":"Akyea","year":"2023","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"9","key":"10.1016\/j.intimp.2024.113722_b0250","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1136\/annrheumdis-2016-210973","article-title":"Stroke in systemic lupus erythematosus: a Swedish population-based cohort study","volume":"76","author":"Arkema","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.intimp.2024.113722_b0255","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1177\/17474930231174227","article-title":"Severe lupus flare is associated with a much higher risk of stroke among patients with SLE","volume":"18","author":"Chang","year":"2023","journal-title":"Int J Stroke"},{"issue":"1","key":"10.1016\/j.intimp.2024.113722_b0260","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2015-000168","article-title":"Stroke in systemic lupus erythematosus: a meta-analysis of population-based cohort studies","volume":"1","author":"Holmqvist","year":"2015","journal-title":"RMD Open"},{"issue":"1","key":"10.1016\/j.intimp.2024.113722_b0265","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.semarthrit.2012.12.002","article-title":"The epidemiology of atherosclerotic cardiovascular disease among patients with SLE: a systematic review","volume":"43","author":"Schoenfeld","year":"2013","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.intimp.2024.113722_b0270","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jaut.2016.10.004","article-title":"The antiphospholipid syndrome in patients with systemic lupus erythematosus","volume":"76","author":"Pons-Estel","year":"2017","journal-title":"J Autoimmun"},{"issue":"5","key":"10.1016\/j.intimp.2024.113722_b0275","first-page":"709","article-title":"The risk of cardiovascular morbidity and cardiovascular mortality in systemic lupus erythematosus and lupus nephritis: a Danish nationwide population-based cohort study","volume":"56","author":"Hermansen","year":"2017","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.intimp.2024.113722_b0280","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12933-022-01532-6","article-title":"Empagliflozin attenuates cardiac microvascular ischemia\/reperfusion injury through improving mitochondrial homeostasis","volume":"21","author":"Zou","year":"2022","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"10.1016\/j.intimp.2024.113722_b0285","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00018-023-05078-y","article-title":"Mitochondrial oxidative damage reprograms lipid metabolism of renal tubular epithelial cells in the diabetic kidney","volume":"81","author":"Hou","year":"2024","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.intimp.2024.113722_b0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115576","article-title":"Telomerase reverse transcriptase restores pancreatic microcirculation profiles and attenuates endothelial dysfunction by inhibiting mitochondrial superoxide production: A potential target for acute pancreatitis therapy","volume":"167","author":"Wang","year":"2023","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"10.1016\/j.intimp.2024.113722_b0295","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1002\/j.2040-4603.2016.tb00718.x","article-title":"Role of Mitochondria in Cerebral Vascular Function: Energy Production, Cellular Protection, and Regulation of Vascular Tone","volume":"6","author":"Busija","year":"2016","journal-title":"Compr Physiol"},{"issue":"2","key":"10.1016\/j.intimp.2024.113722_b0300","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3390\/biomedicines9020169","article-title":"Different Roles of Mitochondria in Cell Death and Inflammation: Focusing on Mitochondrial Quality Control in Ischemic Stroke and Reperfusion","volume":"9","author":"Carinci","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.intimp.2024.113722_b0305","article-title":"Dysfunction of Mitochondrial Ca(2+) Regulatory Machineries in Brain Aging and Neurodegenerative Diseases. Front Cell","volume":"8","author":"Jung","year":"2020","journal-title":"Dev Biol"},{"issue":"10446","key":"10.1016\/j.intimp.2024.113722_b0310","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1016\/S0140-6736(24)00642-1","article-title":"Stroke","volume":"403","author":"Hilkens","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2024.113722_b0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114671","article-title":"The role of mitochondrial dynamics in cerebral ischemia-reperfusion injury","volume":"162","author":"Huang","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.intimp.2024.113722_b0320","article-title":"The Role of Immunometabolism in the Pathogenesis of Systemic Lupus Erythematosus","volume":"12","author":"Robinson","year":"2021","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.intimp.2024.113722_b0325","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25116162","article-title":"Mitochondrial Dysfunction in Systemic Lupus Erythematosus with a Focus on Lupus Nephritis","volume":"25","author":"Halfon","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"9","key":"10.1016\/j.intimp.2024.113722_b0330","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3390\/diseases12090226","article-title":"Mitochondrial Dysfunction in Systemic Lupus Erythematosus: Insights and Therapeutic Potential","volume":"12","author":"Poznyak","year":"2024","journal-title":"Diseases"},{"issue":"17","key":"10.1016\/j.intimp.2024.113722_b0335","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1001\/jama.2024.2315","article-title":"Systemic Lupus Erythematosus: A Review","volume":"331","author":"Siegel","year":"2024","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.intimp.2024.113722_b0340","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/1756-185X.13817","article-title":"State-of-the-art treatment of systemic lupus erythematosus","volume":"23","author":"Tanaka","year":"2020","journal-title":"Int J Rheum Dis"},{"issue":"3","key":"10.1016\/j.intimp.2024.113722_b0345","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.cyto.2011.08.026","article-title":"The role of Tumor Necrosis Factor-alpha (TNF-\u03b1) in the pathogenesis of systemic lupus erythematosus","volume":"56","author":"Postal","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.intimp.2024.113722_b0350","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.703972","article-title":"Targeting Mitochondrial-Derived Reactive Oxygen Species in T Cell-Mediated Autoimmune Diseases","volume":"12","author":"Ch\u00e1vez","year":"2021","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.intimp.2024.113722_b0355","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/path.6081","article-title":"IFN-\u03b3 and androgens disrupt mitochondrial function in murine myocytes","volume":"260","author":"Fenimore","year":"2023","journal-title":"J Pathol"},{"key":"10.1016\/j.intimp.2024.113722_b0360","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/978-1-60761-720-4_4","article-title":"Assessment of mitochondrial dysfunction in lymphocytes of patients with systemic lupus erythematosus","volume":"900","author":"Perl","year":"2012","journal-title":"Methods Mol Biol"},{"issue":"11","key":"10.1016\/j.intimp.2024.113722_b0365","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20221085","article-title":"Chronic activation of pDCs in autoimmunity is linked to dysregulated ER stress and metabolic responses","volume":"219","author":"Chaudhary","year":"2022","journal-title":"J Exp Med"},{"issue":"7","key":"10.1016\/j.intimp.2024.113722_b0370","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1093\/rheumatology\/keab824","article-title":"An enhanced mitochondrial function through glutamine metabolism in plasmablast differentiation in systemic lupus erythematosus","volume":"61","author":"Sumikawa","year":"2022","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"10.1016\/j.intimp.2024.113722_b0375","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.3390\/ijms22083903","article-title":"Mitophagy in Human Diseases","volume":"22","author":"Doblado","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"24","key":"10.1016\/j.intimp.2024.113722_b0380","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abo4271","article-title":"C. CD38 reduces mitochondrial fitness and cytotoxic T cell response against viral infection in lupus patients by suppressing mitophagy","volume":"8","author":"Chen","year":"2022","journal-title":"Sci Adv"},{"issue":"7285","key":"10.1016\/j.intimp.2024.113722_b0385","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nature08780","article-title":"Circulating mitochondrial DAMPs cause inflammatory responses to injury","volume":"464","author":"Zhang","year":"2010","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.intimp.2024.113722_b0390","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.immuni.2012.01.009","article-title":"Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis","volume":"36","author":"Shimada","year":"2012","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.intimp.2024.113722_b0395","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1113\/JP271301","article-title":"Mitochondrial dynamics, mitophagy and cardiovascular disease","volume":"594","author":"V\u00e1squez-Trincado","year":"2016","journal-title":"J Physiol"},{"key":"10.1016\/j.intimp.2024.113722_b0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154545","article-title":"Xuanfei Baidu formula alleviates impaired mitochondrial dynamics and activated NLRP3 inflammasome by repressing NF-\u03baB and MAPK pathways in LPS-induced ALI and inflammation models","volume":"108","author":"Li","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.intimp.2024.113722_b0405","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1146\/annurev-immunol-081022-021207","article-title":"Structural Mechanisms of NLRP3 Inflammasome Assembly and Activation","volume":"41","author":"Fu","year":"2023","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.intimp.2024.113722_b0410","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.mito.2018.06.002","article-title":"Gene therapy for the mitochondrial genome: Purging mutations, pacifying ailments","volume":"46","author":"Aravintha","year":"2019","journal-title":"Mitochondrion"},{"issue":"12","key":"10.1016\/j.intimp.2024.113722_b0415","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0355-7","article-title":"Mitochondrial dysfunction and oxidative stress in heart disease","volume":"51","author":"Peoples","year":"2019","journal-title":"Exp Mol Med"},{"issue":"6","key":"10.1016\/j.intimp.2024.113722_b0420","doi-asserted-by":"crossref","first-page":"L1005","DOI":"10.1152\/ajplung.2000.279.6.L1005","article-title":"Reactive oxygen species in cell signaling","volume":"279","author":"Thannickal","year":"2000","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"9","key":"10.1016\/j.intimp.2024.113722_b0425","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.3390\/ijms23094820","article-title":"The Mighty Mitochondria Are Unifying Organelles and Metabolic Hubs in Multiple Organs of Obesity, Insulin Resistance, Metabolic Syndrome, and Type 2 Diabetes: An Observational Ultrastructure Study","volume":"23","author":"Hayden","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"3322","key":"10.1016\/j.intimp.2024.113722_b0430","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1126\/science.128.3322.450","article-title":"Oxidative phosphorylation","volume":"128","author":"Lehninger","year":"1958","journal-title":"Science"},{"key":"10.1016\/j.intimp.2024.113722_b0435","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1146\/annurev.bi.38.070169.005015","article-title":"Oxidative phosphorylation in mitochondria","volume":"38","author":"Lardy","year":"1969","journal-title":"Annu Rev Biochem"},{"issue":"23","key":"10.1016\/j.intimp.2024.113722_b0440","doi-asserted-by":"crossref","first-page":"7023","DOI":"10.1113\/JP273839","article-title":"Oxidative phosphorylation: regulation and role in cellular and tissue metabolism","volume":"595","author":"Wilson","year":"2017","journal-title":"J Physiol"},{"issue":"16","key":"10.1016\/j.intimp.2024.113722_b0445","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.3390\/ijms20163878","article-title":"Molecular and Cellular Bases of Immunosenescence, Inflammation, and Cardiovascular Complications Mimicking \u201cInflammaging\u201d in Patients with Systemic Lupus Erythematosus","volume":"20","author":"Tsai","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.intimp.2024.113722_b0450","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrrheum.2013.147","article-title":"Oxidative stress in the pathology and treatment of systemic lupus erythematosus","volume":"9","author":"Perl","year":"2013","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"10.1016\/j.intimp.2024.113722_b0455","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.cmet.2020.07.001","article-title":"Mitochondrial Oxidative Damage Underlies Regulatory T Cell Defects in Autoimmunity","volume":"32","author":"Alissafi","year":"2020","journal-title":"Cell Metab"},{"key":"10.1016\/j.intimp.2024.113722_b0460","article-title":"Imbalance of Th17 cells, Treg cells and associated cytokines in patients with systemic lupus erythematosus: a meta-analysis","volume":"15","author":"Huang","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.intimp.2024.113722_b0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102870","article-title":"Abnormalities of T cells in systemic lupus erythematosus: new insights in pathogenesis and therapeutic strategies","volume":"132","author":"Li","year":"2022","journal-title":"J Autoimmun"},{"issue":"1","key":"10.1016\/j.intimp.2024.113722_b0470","doi-asserted-by":"crossref","first-page":"17842","DOI":"10.1038\/s41598-021-96262-2","article-title":"Monocyte-derived and M1 macrophages from ankylosing spondylitis patients released higher TNF-\u03b1 and expressed more IL1B in response to BzATP than macrophages from healthy subjects","volume":"11","author":"Akhtari","year":"2021","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.intimp.2024.113722_b0475","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.semarthrit.2020.05.011","article-title":"High-density lipoprotein functionality in systemic lupus erythematosus","volume":"50","author":"Ganjali","year":"2020","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.intimp.2024.113722_b0480","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/art.41059","article-title":"High-Density Lipoprotein in Lupus: Disease Biomarkers and Potential Therapeutic Strategy","volume":"72","author":"Kim","year":"2020","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"10.1016\/j.intimp.2024.113722_b0485","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1002\/art.21976","article-title":"Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis","volume":"54","author":"McMahon","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.intimp.2024.113722_b0490","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/oxfordjournals.aje.a009122","article-title":"Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study","volume":"145","author":"Manzi","year":"1997","journal-title":"Am J Epidemiol"},{"issue":"3","key":"10.1016\/j.intimp.2024.113722_b0495","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41577-022-00760-x","article-title":"Mitochondrial control of inflammation","volume":"23","author":"Marchi","year":"2023","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.intimp.2024.113722_b0500","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/1529-0131(200201)46:1<175::AID-ART10015>3.0.CO;2-H","article-title":"Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus","volume":"46","author":"Gergely","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.intimp.2024.113722_b0505","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/BOR.0000000000000088","article-title":"The inflammasome and lupus: another innate immune mechanism contributing to disease pathogenesis?","volume":"26","author":"Kahlenberg","year":"2014","journal-title":"Curr Opin Rheumatol"},{"issue":"20","key":"10.1016\/j.intimp.2024.113722_b0510","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.130062","article-title":"PD-1hiCXCR5- T peripheral helper cells promote B cell responses in lupus via MAF and IL-21","volume":"4","author":"Bocharnikov","year":"2019","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.intimp.2024.113722_b0515","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41591-018-0254-9","article-title":"A CD4(+) T cell population expanded in lupus blood provides B cell help through interleukin-10 and succinate","volume":"25","author":"Caielli","year":"2019","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.intimp.2024.113722_b0520","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.cmet.2023.01.009","article-title":"Sodium perturbs mitochondrial respiration and induces dysfunctional Tregs","volume":"35","author":"C\u00f4rte-Real","year":"2023","journal-title":"Cell Metab"},{"issue":"7329","key":"10.1016\/j.intimp.2024.113722_b0525","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature09663","article-title":"A role for mitochondria in NLRP3 inflammasome activation","volume":"469","author":"Zhou","year":"2011","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.intimp.2024.113722_b0530","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1089\/ars.2014.5994","article-title":"Redox regulation of NLRP3 inflammasomes: ROS as trigger or effector?","volume":"22","author":"Abais","year":"2015","journal-title":"Antioxid Redox Signal"},{"issue":"13","key":"10.1016\/j.intimp.2024.113722_b0535","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.3390\/ijms20133328","article-title":"The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation","volume":"20","author":"Kelley","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.intimp.2024.113722_b0540","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/nm.4027","article-title":"Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease","volume":"22","author":"Lood","year":"2016","journal-title":"Nat Med"},{"issue":"4 Suppl 98","key":"10.1016\/j.intimp.2024.113722_b0545","first-page":"21","article-title":"The importance of the type I interferon system in autoimmunity","volume":"34","author":"R\u00f6nnblom","year":"2016","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"10.1016\/j.intimp.2024.113722_b0550","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/mco2.69","article-title":"The emerging role of neutrophils in autoimmune-associated disorders: effector, predictor, and therapeutic targets","volume":"2","author":"Fu","year":"2020","journal-title":"MedComm"},{"issue":"5","key":"10.1016\/j.intimp.2024.113722_b0555","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.celrep.2019.09.050","article-title":"Mitochondrial Damage Causes Inflammation via cGAS-STING Signaling in Acute Kidney Injury","volume":"29","author":"Maekawa","year":"2019","journal-title":"Cell Rep"},{"issue":"3","key":"10.1016\/j.intimp.2024.113722_b0560","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.immuni.2020.02.002","article-title":"mtDNA Activates cGAS Signaling and Suppresses the YAP-Mediated Endothelial Cell Proliferation Program to Promote Inflammatory Injury","volume":"52","author":"Huang","year":"2020","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.intimp.2024.113722_b0565","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1191\/0961203305lu2216oa","article-title":"Oxidant stress, inflammation and atherogenesis","volume":"14","author":"Dav\u00ec","year":"2005","journal-title":"Lupus"},{"key":"10.1016\/j.intimp.2024.113722_b0570","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3389\/fcvm.2019.00153","article-title":"Role of Platelet Mitochondria: Life in a Nucleus-Free Zone","volume":"6","author":"Melchinger","year":"2019","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"10.1016\/j.intimp.2024.113722_b0575","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1042\/BST20120327","article-title":"Platelet mitochondrial function: from regulation of thrombosis to biomarker of disease","volume":"41","author":"Zharikov","year":"2013","journal-title":"Biochem Soc Trans"},{"issue":"2","key":"10.1016\/j.intimp.2024.113722_b0580","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10555-017-9677-x","article-title":"Normal platelet function","volume":"36","author":"Holinstat","year":"2017","journal-title":"Cancer Metastasis Rev"},{"issue":"1","key":"10.1016\/j.intimp.2024.113722_b0585","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4065\/81.1.59","article-title":"Platelets in atherothrombosis","volume":"81","author":"Vorchheimer","year":"2006","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"10.1016\/j.intimp.2024.113722_b0590","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jjcc.2013.09.014","article-title":"Platelet activation and thrombus formation relates to the presence of myocardial inflammation in patients with cardiomyopathy","volume":"63","author":"Bobbert","year":"2014","journal-title":"J Cardiol"},{"issue":"581","key":"10.1016\/j.intimp.2024.113722_b0595","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav5928","article-title":"Platelets release mitochondrial antigens in systemic lupus erythematosus","volume":"13","author":"Melki","year":"2021","journal-title":"Sci Transl Med"},{"issue":"8","key":"10.1016\/j.intimp.2024.113722_b0600","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11926-017-0678-0","article-title":"New Insights on Platelets and Platelet-Derived Microparticles in Systemic Lupus Erythematosus","volume":"19","author":"Scherlinger","year":"2017","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.intimp.2024.113722_b0605","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ijcard.2017.02.107","article-title":"Circulating microparticle subpopulations in systemic lupus erythematosus are affected by disease activity","volume":"236","author":"L\u00f3pez","year":"2017","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1016\/j.intimp.2024.113722_b0610","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/art.39417","article-title":"Circulating Apoptotic Microparticles in Systemic Lupus Erythematosus Patients Drive the Activation of Dendritic Cell Subsets and Prime Neutrophils for NETosis","volume":"68","author":"Dieker","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.intimp.2024.113722_b0615","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jaut.2019.05.003","article-title":"Microparticles in the blood of patients with SLE: Size, content of mitochondria and role in circulating immune complexes","volume":"102","author":"Mobarrez","year":"2019","journal-title":"J Autoimmun"},{"issue":"2","key":"10.1016\/j.intimp.2024.113722_b0620","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.molmed.2009.12.005","article-title":"Pathogenesis of human systemic lupus erythematosus: recent advances","volume":"16","author":"Crisp\u00edn","year":"2010","journal-title":"Trends Mol Med"},{"issue":"1","key":"10.1016\/j.intimp.2024.113722_b0625","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jmb.2016.10.028","article-title":"Mitochondria as Molecular Platforms Integrating Multiple Innate Immune Signalings","volume":"429","author":"Monlun","year":"2017","journal-title":"J Mol Biol"},{"issue":"3","key":"10.1016\/j.intimp.2024.113722_b0630","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.immuni.2015.02.002","article-title":"Mitochondria in the regulation of innate and adaptive immunity","volume":"42","author":"Weinberg","year":"2015","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.intimp.2024.113722_b0635","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.clim.2012.07.001","article-title":"Metabolic regulation of organelle homeostasis in lupus T cells","volume":"144","author":"Caza","year":"2012","journal-title":"Clin Immunol"},{"issue":"9","key":"10.1016\/j.intimp.2024.113722_b0640","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1002\/art.22085","article-title":"Rapamycin reduces disease activity and normalizes T cell activation-induced calcium fluxing in patients with systemic lupus erythematosus","volume":"54","author":"Fernandez","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.intimp.2024.113722_b0645","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1136\/annrheumdis-2013-203759","article-title":"Dysregulated CD4+ T cells from SLE-susceptible mice are sufficient to accelerate atherosclerosis in LDLr-\/- mice","volume":"74","author":"Wilhelm","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.intimp.2024.113722_b0650","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2024.110218","article-title":"T cell involvement in antiphospholipid syndrome","volume":"263","author":"Tektonidou","year":"2024","journal-title":"Clin Immunol"},{"key":"10.1016\/j.intimp.2024.113722_b0655","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.588776","article-title":"T Cells in Autoimmunity-Associated Cardiovascular Diseases","volume":"11","author":"Schwartz","year":"2020","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.intimp.2024.113722_b0660","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/BOR.0b013e328363eba3","article-title":"Cardiovascular disease in lupus: insights and updates","volume":"25","author":"Knight","year":"2013","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.intimp.2024.113722_b0665","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.trsl.2018.07.014","article-title":"Mitochondria in innate immune signaling","volume":"202","author":"Banoth","year":"2018","journal-title":"Transl Res"},{"issue":"9","key":"10.1016\/j.intimp.2024.113722_b0670","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s13238-020-00713-x","article-title":"BMAL1 regulates mitochondrial fission and mitophagy through mitochondrial protein BNIP3 and is critical in the development of dilated cardiomyopathy","volume":"11","author":"Li","year":"2020","journal-title":"Protein Cell"},{"issue":"1","key":"10.1016\/j.intimp.2024.113722_b0675","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/icb.2014.75","article-title":"Keeping the immune system in check: a role for mitophagy","volume":"93","author":"Lazarou","year":"2015","journal-title":"Immunol Cell Biol"},{"issue":"10","key":"10.1016\/j.intimp.2024.113722_b0680","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1084\/jem.20101664","article-title":"Type I interferon: friend or foe?","volume":"207","author":"Trinchieri","year":"2010","journal-title":"J Exp Med"},{"issue":"8","key":"10.1016\/j.intimp.2024.113722_b0685","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1182\/blood-2007-05-089086","article-title":"Interferon-alpha promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis","volume":"110","author":"Denny","year":"2007","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.intimp.2024.113722_b0690","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1182\/blood-2010-03-274605","article-title":"Platelet transcriptional profile and protein expression in patients with systemic lupus erythematosus: up-regulation of the type I interferon system is strongly associated with vascular disease","volume":"116","author":"Lood","year":"2010","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.intimp.2024.113722_b0695","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1002\/art.34504","article-title":"Type I interferons modulate vascular function, repair, thrombosis, and plaque progression in murine models of lupus and atherosclerosis","volume":"64","author":"Thacker","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.intimp.2024.113722_b0700","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.cmet.2010.06.008","article-title":"Myeloid type I interferon signaling promotes atherosclerosis by stimulating macrophage recruitment to lesions","volume":"12","author":"Goossens","year":"2010","journal-title":"Cell Metab"},{"issue":"11","key":"10.1016\/j.intimp.2024.113722_b0705","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1161\/ATVBAHA.112.251314","article-title":"Plasmacytoid dendritic cells play a key role in promoting atherosclerosis in apolipoprotein E-deficient mice","volume":"32","author":"Macritchie","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"10.1016\/j.intimp.2024.113722_b0710","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1161\/hq1201.100220","article-title":"Immune mechanisms in atherosclerosis","volume":"21","author":"Hansson","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"10.1016\/j.intimp.2024.113722_b0715","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1161\/01.RES.63.4.712","article-title":"Gamma-interferon regulates vascular smooth muscle proliferation and Ia antigen expression in vivo and in vitro","volume":"63","author":"Hansson","year":"1988","journal-title":"Circ Res"},{"key":"10.1016\/j.intimp.2024.113722_b0720","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1146\/annurev.immunol.21.120601.140942","article-title":"Molecular mechanisms regulating Th1 immune responses","volume":"21","author":"Szabo","year":"2003","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"10.1016\/j.intimp.2024.113722_b0725","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/cvr\/cvq195","article-title":"Endothelial mitochondria and heart disease","volume":"88","author":"Davidson","year":"2010","journal-title":"Cardiovasc Res"},{"issue":"8","key":"10.1016\/j.intimp.2024.113722_b0730","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1161\/01.RES.0000261970.18328.1d","article-title":"Endothelial mitochondria: contributing to vascular function and disease","volume":"100","author":"Davidson","year":"2007","journal-title":"Circ Res"},{"issue":"4","key":"10.1016\/j.intimp.2024.113722_b0735","doi-asserted-by":"crossref","first-page":"C836","DOI":"10.1152\/ajpcell.00011.2005","article-title":"Modulation of mitochondrial Ca2+ by nitric oxide in cultured bovine vascular endothelial cells","volume":"289","author":"Dedkova","year":"2005","journal-title":"Am J Physiol Cell Physiol"},{"issue":"2","key":"10.1016\/j.intimp.2024.113722_b0740","doi-asserted-by":"crossref","first-page":"C406","DOI":"10.1152\/ajpcell.00155.2003","article-title":"Mitochondrial calcium uptake stimulates nitric oxide production in mitochondria of bovine vascular endothelial cells","volume":"286","author":"Dedkova","year":"2004","journal-title":"Am J Physiol Cell Physiol"},{"issue":"11","key":"10.1016\/j.intimp.2024.113722_b0745","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1182\/blood-2009-04-215335","article-title":"Naturally occurring free thiols within beta 2-glycoprotein I in vivo: nitrosylation, redox modification by endothelial cells, and regulation of oxidative stress-induced cell injury","volume":"116","author":"Ioannou","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2024.113722_b0750","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1538-7836.2011.04301.x","article-title":"Molecular pathophysiology of the antiphospholipid syndrome: the role of oxidative post-translational modification of beta 2 glycoprotein I","volume":"9","author":"Passam","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"9","key":"10.1016\/j.intimp.2024.113722_b0755","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1002\/art.30383","article-title":"Novel assays of thrombogenic pathogenicity in the antiphospholipid syndrome based on the detection of molecular oxidative modification of the major autoantigen \u03b22-glycoprotein I","volume":"63","author":"Ioannou","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"32","key":"10.1016\/j.intimp.2024.113722_b0760","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.2174\/092986710793205444","article-title":"Oxidative stress and endothelial dysfunction in cardiovascular disease: mitochondria-targeted therapeutics","volume":"17","author":"Rocha","year":"2010","journal-title":"Curr Med Chem"},{"issue":"8","key":"10.1016\/j.intimp.2024.113722_b0765","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1161\/hh0801.089861","article-title":"Nitric oxide insufficiency, platelet activation, and arterial thrombosis","volume":"88","author":"Loscalzo","year":"2001","journal-title":"Circ Res"},{"issue":"15","key":"10.1016\/j.intimp.2024.113722_b0770","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1161\/01.CIR.98.15.1481","article-title":"Impaired platelet production of nitric oxide predicts presence of acute coronary syndromes","volume":"98","author":"Freedman","year":"1998","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.intimp.2024.113722_b0775","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/clc.4960210705","article-title":"Inducible nitric oxide synthase and atherosclerosis","volume":"21","author":"Ikeda","year":"1998","journal-title":"Clin Cardiol"},{"issue":"5","key":"10.1016\/j.intimp.2024.113722_b0780","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/01.RES.0000088351.58510.21","article-title":"Nitric oxide and cardiac function: ten years after, and continuing","volume":"93","author":"Massion","year":"2003","journal-title":"Circ Res"},{"issue":"23","key":"10.1016\/j.intimp.2024.113722_b0785","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1161\/01.CIR.99.23.3009","article-title":"Endomyocardial nitric oxide synthase and left ventricular preload reserve in dilated cardiomyopathy","volume":"99","author":"Heymes","year":"1999","journal-title":"Circulation"},{"issue":"9009","key":"10.1016\/j.intimp.2024.113722_b0790","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0140-6736(96)90610-8","article-title":"Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy","volume":"347","author":"Habib","year":"1996","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.intimp.2024.113722_b0795","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ecl.2013.09.009","article-title":"Metabolic syndrome","volume":"43","author":"Samson","year":"2014","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"2","key":"10.1016\/j.intimp.2024.113722_b0800","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1136\/ard.2006.054973","article-title":"High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors","volume":"66","author":"Chung","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.intimp.2024.113722_b0805","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1161\/CIRCRESAHA.116.306842","article-title":"Lipid Use and Misuse by the Heart","volume":"118","author":"Schulze","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.intimp.2024.113722_b0810","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.742178","article-title":"Inflammation in Metabolic Cardiomyopathy","volume":"8","author":"Wenzl","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"11","key":"10.1016\/j.intimp.2024.113722_b0815","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.2337\/db11-1805","article-title":"Increased myocardial uptake of dietary fatty acids linked to cardiac dysfunction in glucose-intolerant humans","volume":"61","author":"Labb\u00e9","year":"2012","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.intimp.2024.113722_b0820","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/mrm.10372","article-title":"Myocardial triglycerides and systolic function in humans: in vivo evaluation by localized proton spectroscopy and cardiac imaging","volume":"49","author":"Szczepaniak","year":"2003","journal-title":"Magn Reson Med"},{"issue":"9","key":"10.1016\/j.intimp.2024.113722_b0825","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.82922","article-title":"Increased de novo ceramide synthesis and accumulation in failing myocardium","volume":"2","author":"Ji","year":"2017","journal-title":"JCI Insight"},{"issue":"10","key":"10.1016\/j.intimp.2024.113722_b0830","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1194\/jlr.M800147-JLR200","article-title":"Ceramide is a cardiotoxin in lipotoxic cardiomyopathy","volume":"49","author":"Park","year":"2008","journal-title":"J Lipid Res"},{"issue":"23","key":"10.1016\/j.intimp.2024.113722_b0835","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1161\/CIRCULATIONAHA.111.060889","article-title":"Ventricular assist device implantation corrects myocardial lipotoxicity, reverses insulin resistance, and normalizes cardiac metabolism in patients with advanced heart failure","volume":"125","author":"Chokshi","year":"2012","journal-title":"Circulation"},{"issue":"7293","key":"10.1016\/j.intimp.2024.113722_b0840","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/nature08991","article-title":"Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK\/SIRT1","volume":"464","author":"Iwabu","year":"2010","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.intimp.2024.113722_b0845","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.2337\/db22-0728","article-title":"A Defect in Mitochondrial Complex III but Not in Complexes I or IV Causes Early \u03b2-Cell Dysfunction and Hyperglycemia in Mice","volume":"72","author":"Lang","year":"2023","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.intimp.2024.113722_b0850","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrrheum.2013.157","article-title":"Pragmatic approaches to therapy for systemic lupus erythematosus","volume":"10","author":"Xiong","year":"2014","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"10.1016\/j.intimp.2024.113722_b0855","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11926-010-0141-y","article-title":"Use of hydroxychloroquine to prevent thrombosis in systemic lupus erythematosus and in antiphospholipid antibody-positive patients","volume":"13","author":"Petri","year":"2011","journal-title":"Curr Rheumatol Rep"},{"issue":"7","key":"10.1016\/j.intimp.2024.113722_b0860","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.3899\/jrheum.161351","article-title":"Longterm Hydroxychloroquine Therapy and Low-dose Aspirin May Have an Additive Effectiveness in the Primary Prevention of Cardiovascular Events in Patients with Systemic Lupus Erythematosus","volume":"44","author":"Fasano","year":"2017","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.intimp.2024.113722_b0865","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1152\/physrev.00026.2013","article-title":"Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release","volume":"94","author":"Zorov","year":"2014","journal-title":"Physiol Rev"},{"issue":"3","key":"10.1016\/j.intimp.2024.113722_b0870","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.cell.2015.10.001","article-title":"Mitochondrial ROS signaling in organismal homeostasis","volume":"163","author":"Shadel","year":"2015","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.intimp.2024.113722_b0875","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.3109\/10715762.2012.717273","article-title":"Susceptibility of mitochondrial electron-transport complexes to oxidative damage. Focus on cytochrome c oxidase","volume":"46","author":"Musatov","year":"2012","journal-title":"Free Radic Res"},{"issue":"9","key":"10.1016\/j.intimp.2024.113722_b0880","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1002\/art.34502","article-title":"N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial","volume":"64","author":"Lai","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.intimp.2024.113722_b0885","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/art.37893","article-title":"Attention deficit and hyperactivity disorder scores are elevated and respond to N-acetylcysteine treatment in patients with systemic lupus erythematosus","volume":"65","author":"Garcia","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.intimp.2024.113722_b0890","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1007\/s00421-020-04396-4","article-title":"MitoQ and CoQ10 supplementation mildly suppresses skeletal muscle mitochondrial hydrogen peroxide levels without impacting mitochondrial function in middle-aged men","volume":"120","author":"Pham","year":"2020","journal-title":"Eur J Appl Physiol"},{"issue":"9","key":"10.1016\/j.intimp.2024.113722_b0895","doi-asserted-by":"crossref","first-page":"4923","DOI":"10.3390\/ijms25094923","article-title":"Anticancer Effects of Mitoquinone via Cell Cycle Arrest and Apoptosis in Canine Mammary Gland Tumor Cells","volume":"25","author":"Lee","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.intimp.2024.113722_b0900","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/art.41128","article-title":"Improved Mitochondrial Metabolism and Reduced Inflammation Following Attenuation of Murine Lupus With Coenzyme Q10 Analog Idebenone","volume":"72","author":"Blanco","year":"2020","journal-title":"Arthritis Rheumatol"},{"issue":"464","key":"10.1016\/j.intimp.2024.113722_b0905","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aaf7478","article-title":"AMPK promotes mitochondrial biogenesis and function by phosphorylating the epigenetic factors DNMT1, RBBP7, and HAT1","volume":"10","author":"Marin","year":"2017","journal-title":"Sci Signal"},{"issue":"9","key":"10.1016\/j.intimp.2024.113722_b0910","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/ncb2329","article-title":"The AMPK signalling pathway coordinates cell growth, autophagy and metabolism","volume":"13","author":"Mihaylova","year":"2011","journal-title":"Nat Cell Biol"},{"issue":"1","key":"10.1016\/j.intimp.2024.113722_b0915","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1677\/JOE-08-0278","article-title":"Metformin induces oxidative stress in white adipocytes and raises uncoupling protein 2 levels","volume":"199","author":"Anedda","year":"2008","journal-title":"J Endocrinol"},{"issue":"1","key":"10.1016\/j.intimp.2024.113722_b0920","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2337\/diabetes.55.01.06.db05-0943","article-title":"Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells","volume":"55","author":"Kukidome","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.intimp.2024.113722_b0925","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112149","article-title":"Abnormal energy metabolism in the pathogenesis of systemic lupus erythematosus","volume":"134","author":"Cao","year":"2024","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"10.1016\/j.intimp.2024.113722_b0930","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2020-000429","article-title":"Effects of metformin on disease flares in patients with systemic lupus erythematosus: post hoc analyses from two randomised trials","volume":"7","author":"Sun","year":"2020","journal-title":"Lupus Sci Med"},{"issue":"3","key":"10.1016\/j.intimp.2024.113722_b0935","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nrrheum.2015.172","article-title":"Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases","volume":"12","author":"Perl","year":"2016","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"10.1016\/j.intimp.2024.113722_b0940","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1615\/CritRevImmunol.2016017164","article-title":"Metabolic Factors that Contribute to Lupus Pathogenesis","volume":"36","author":"Li","year":"2016","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.intimp.2024.113722_b0945","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.3389\/fimmu.2020.01027","article-title":"T Cell Metabolism: A New Perspective on Th17\/Treg Cell Imbalance in Systemic Lupus Erythematosus","volume":"11","author":"Shan","year":"2020","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.intimp.2024.113722_b0950","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/nrrheum.2017.43","article-title":"Immunometabolism in systemic lupus erythematosus","volume":"13","author":"Morel","year":"2017","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"10.1016\/j.intimp.2024.113722_b0955","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/art.40380","article-title":"Blockade of Treg Cell Differentiation and Function by the Interleukin-21-Mechanistic Target of Rapamycin Axis Via Suppression of Autophagy in Patients With Systemic Lupus Erythematosus","volume":"70","author":"Kato","year":"2018","journal-title":"Arthritis Rheumatol"},{"issue":"10126","key":"10.1016\/j.intimp.2024.113722_b0960","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/S0140-6736(18)30485-9","article-title":"Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1\/2 trial","volume":"391","author":"Lai","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2024.113722_b0965","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X20953336","article-title":"Clinical efficacy and safety of sirolimus in systemic lupus erythematosus: a real-world study and meta-analysis","volume":"12","author":"Peng","year":"2020","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.intimp.2024.113722_b0970","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2021.108781","article-title":"Improvement of renal and non-renal SLE outcome measures on sirolimus therapy - A 21-year follow-up study of 73 patients","volume":"229","author":"Piranavan","year":"2021","journal-title":"Clin Immunol"},{"issue":"1","key":"10.1016\/j.intimp.2024.113722_b0975","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/nyas.13557","article-title":"Cardioprotective effects of dietary rapamycin on adult female C57BLKS\/J\u2010Leprdb mice","volume":"1418","author":"Reifsnyder","year":"2018","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"7","key":"10.1016\/j.intimp.2024.113722_b0980","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1681\/ASN.2007111202","article-title":"Sirolimus is associated with new-onset diabetes in kidney transplant recipients","volume":"19","author":"Johnston","year":"2008","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.intimp.2024.113722_b0985","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/phar.1692","article-title":"Time-Dependent and Immunosuppressive Drug-Associated Adverse Event Profiles in De Novo Kidney Transplant Recipients Converted from Tacrolimus to Sirolimus Regimens","volume":"36","author":"Felix","year":"2016","journal-title":"Pharmacotherapy"},{"issue":"6076","key":"10.1016\/j.intimp.2024.113722_b0990","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1126\/science.1215135","article-title":"Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity","volume":"335","author":"Lamming","year":"2012","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.intimp.2024.113722_b0995","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nri.2016.33","article-title":"Inflammasome: Anti-inflammatory effect of mitophagy","volume":"16","author":"Minton","year":"2016","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"10.1016\/j.intimp.2024.113722_b1000","doi-asserted-by":"crossref","first-page":"5379","DOI":"10.3390\/ijms22105379","article-title":"Rapamycin Ameliorates Defects in Mitochondrial Fission and Mitophagy in Glioblastoma Cells","volume":"22","author":"Lenzi","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.intimp.2024.113722_b1005","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.kint.2023.12.017","article-title":"Novel mitophagy inducer alleviates lupus nephritis by reducing myeloid cell activation and autoantigen presentation","volume":"105","author":"Wang","year":"2024","journal-title":"Kidney Int"},{"issue":"6472","key":"10.1016\/j.intimp.2024.113722_b1010","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1126\/science.aav4011","article-title":"VDAC oligomers form mitochondrial pores to release mtDNA fragments and promote lupus-like disease","volume":"366","author":"Kim","year":"2019","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.intimp.2024.113722_b1015","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nri.2017.21","article-title":"Mitochondrial DNA in innate immune responses and inflammatory pathology","volume":"17","author":"West","year":"2017","journal-title":"Nat Rev Immunol"},{"issue":"48","key":"10.1016\/j.intimp.2024.113722_b1020","doi-asserted-by":"crossref","first-page":"24986","DOI":"10.1074\/jbc.M116.744284","article-title":"Novel Compounds Targeting the Mitochondrial Protein VDAC1 Inhibit Apoptosis and Protect against Mitochondrial Dysfunction","volume":"291","author":"Ben-Hail","year":"2016","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1016\/j.intimp.2024.113722_b1025","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.2215\/CJN.15040920","article-title":"Long-Term Immunosuppression Management: Opportunities and Uncertainties","volume":"16","author":"Wojciechowski","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.intimp.2024.113722_b1030","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrm.2017.95","article-title":"AMPK: guardian of metabolism and mitochondrial homeostasis","volume":"19","author":"Herzig","year":"2018","journal-title":"Nat Rev Mol Cell Biol"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924022446?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924022446?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:36:42Z","timestamp":1789645002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924022446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":206,"alternative-id":["S1567576924022446"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113722","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mitochondria dysfunction: A trigger for cardiovascular diseases in systemic lupus erythematosus","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113722","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113722"}}